p 152: mesenchymal stem cells as a therapeutic target in multiple sclerosis

Authors

ali shariat razavi medicine faculty, islamic azad university, mashhad branch, mashhad, iran

mohammad reza khojasteh medicine faculty, islamic azad university, mashhad branch, mashhad, iran

aida java zadeh medicine faculty, islamic azad university, mashhad branch, mashhad, iran

sajad sahab negah a. department of neuroscience, mashhad university of medical sciences, mashhad, iran b. shefa neuroscience research center, khatam alanbia hospital, tehran, iranshefa neuroscience research center, khatam alanbia hospital, tehran, iran

abstract

neuroinflammation has a significant role in induce of multiple sclerosis (ms) many approaches have been used to treat ms, but none of these methods have not been able to fully improve. one of the methods can suppress inflammation and regenerate the nervous system is the use of cell therapy. using cell therapy in pre-clinic phase can be realized, it's mechanism and potency to suppress neuroinflammation. the best way that plenty of researchers use it to simulate the ms condition is experimental autoimmune encephalomyelitis (eae) which is method can be induced neuroinflammation in laboratory animals. in this context, a lot of researches have been done on eae model. many of these studies have been done on mesenchymal stem cells (msc). msc is a heterogeneous subset of, mesoderm stromal progenitor cells that are almost derived from connective tissue. mscs can be obtained from adipose tissue, bone marrow, and umbilical cord that regulatory and inhibitory effect on the immune system. transplantation of adipose-derived stem cell (ascs) has demonstrated striking therapeutic effects and unique immunomodulatory capacities when delivered at the peak or later in the course of the disease in eae rats. recent studies have shown that umbilical cord-derived mesenchymal stem cells (uc-mscs) exert a regulatory effect on the functions of immune cells. uc-mscs could improve the impaired function of t-regulator cells (treg) from ms patients and also enhanced the capacity of tregs to release il-10. there is still controversy about the use of uc-mscs and ascs, and more research is needed to determine the advantages and the disadvantages of them also in vitro method such as eae cannot simulate all condition of disease therefor more research in clinical phase should be done.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

P 152: Mesenchymal Stem Cells as a Therapeutic Target in Multiple Sclerosis

Neuroinflammation has a significant role in induce of Multiple sclerosis (MS) many approaches have been used to treat MS, but none of these methods have not been able to fully improve. One of the methods can suppress inflammation and regenerate the nervous system is the use of cell therapy. Using cell therapy in pre-clinic phase can be realized, it's mechanism and potency to suppress neuroinfla...

full text

P 140: Stem Cells in Multiple Sclerosis

Multiple sclerosis (MS) is an inflammatory disease of the central nervous system (CNS). Inflammation caused by immune cells destroy the myelin and then axon. CNS failure to complete repair results in permanent disabilities. Some types of stem cells have special potentials to repair these injuries and even cure MS. Neural crest stem cells with a mutual origin with CNS and the ability of differen...

full text

P 141: Mesenchymal Stem Cells as Treatment in Neuroinflammatory Disease

Mesenchymal stem cells can be obtained from deferent tissues like adipose tissue, umbilical cord, placenta, skin, bone marrow, etc. These cells have regulatory effects on all types of immune cells such as dendritic cell, natural killers and lymphocytes. Mesenchymal stem cells induce inhibitory phenotypes of Antigen Presenting Cells (APCs) following their activity. They also change T cells pheno...

full text

P 125: Treatment of Multiple Sclerosis with Mesenchymal Cells Starfish

Arm grooves of star-fish have mesenchymal stem cells derived from adipose tissue cell. Widespread studies have shown that stem cells derived from adipose-derived mesenchymal stem cell from bone marrow have many similarities in terms of the ability to differentiate into a variety of tissues. Most of the animals live in warm and shallow waters and the waters of this feature is that it is low in d...

full text

Immunomodulatory Effect of Mesenchymal Stem Cells in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis: A Review Study

Multiple Sclerosis (MS) is a chronic inflammatory and demyelinating disease of the central nervous system that may lead to disability of the patient. Current MS treatment regimens are still insufficient and research is conducted for developing more effective therapies capable of targeting neurodegeneration, inflammation, and demyelination. Recent results of experimental and clinical studies in ...

full text

p 140: stem cells in multiple sclerosis

multiple sclerosis (ms) is an inflammatory disease of the central nervous system (cns). inflammation caused by immune cells destroy the myelin and then axon. cns failure to complete repair results in permanent disabilities. some types of stem cells have special potentials to repair these injuries and even cure ms. neural crest stem cells with a mutual origin with cns and the ability of differen...

full text

My Resources

Save resource for easier access later


Journal title:
مجله علوم اعصاب شفای خاتم

جلد ۵، شماره ۲، صفحات ۱۸۳-۱۸۳

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023